Literature DB >> 29024210

A case of anaplastic lymphoma kinase-positive renal cell carcinoma coincident with Hodgkin lymphoma.

Yuzo Oyama1, Haruto Nishida1, Takahiro Kusaba1, Hiroko Kadowaki1, Motoki Arakane1, Tsutomu Daa1, Dai Watanabe2, Yasuyuki Akita2, Fuminori Sato2, Hiromitsu Mimata2, Shigeo Yokoyama1.   

Abstract

We report a case of ALK-positive renal cell carcinoma coincident with Hodgkin lymphoma. The patient was a 19 year-old-girl without sickle cell trait. The right renal tumor was discovered concomitantly with Hodgkin lymphoma (HL). After chemotherapy for HL, right nephrectomy was performed. Microscopically, the tumor showed a solid and focally pseudo-papillary growth pattern studded with tubular structures. Most tumor cells were small bland eosinophilic cells, but rhabdoid cells, vacuolated cells, pleomorphic multinucleated giant cells were also admixed. The variety of growth patterns and cell features led us to speculate a possibility of ALK-positive renal cell carcinoma (ALK + RCC). ALK was immunohistochemically positive, and fluorescence in situ hybridization analysis detected a split signal of the ALK gene. We examined previously reported partner genes (STRN, TPM3, VCL and EML4) by RT-PCR, but fusion gene was not detected. RCC showing solid or cribriform growth patterns with vacuolated cells with intracytoplamic lumina, rhabdoid cells, and mucus production indicates the possibility of ALK + RCC.
© 2017 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  anaplastic lymphoma kinase (ALK); hodgkin lymphoma; kidney; renal cell carcinoma

Mesh:

Substances:

Year:  2017        PMID: 29024210     DOI: 10.1111/pin.12592

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  4 in total

1.  ALK rearrangement-associated renal cell carcinoma morphologically mimicking mucinous tubular and spindle cell carcinoma: a case report.

Authors:  Keita Kai; Shohei Tobu; Shinichi Kido; Shuji Mikami; Kengo Takeuchi; Akito Dobashi; Yuki Togashi; Mitsuru Noguchi; Shinichi Aishima
Journal:  Diagn Pathol       Date:  2022-06-19       Impact factor: 3.196

2.  Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Authors:  Kiril Trpkov; Sean R Williamson; Anthony J Gill; Ondrej Hes; Adebowale J Adeniran; Abbas Agaimy; Reza Alaghehbandan; Mahul B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Jonathan I Epstein; John C Cheville; Eva Comperat; Isabela Werneck da Cunha; Jennifer B Gordetsky; Sounak Gupta; Huiying He; Michelle S Hirsch; Peter A Humphrey; Payal Kapur; Fumiyoshi Kojima; Jose I Lopez; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Santosh Menon; George J Netto; Christopher G Przybycin; Priya Rao; Qiu Rao; Victor E Reuter; Rola M Saleeb; Rajal B Shah; Steven C Smith; Satish Tickoo; Maria S Tretiakova; Lawrence True; Virginie Verkarre; Sara E Wobker; Ming Zhou
Journal:  Mod Pathol       Date:  2021-02-01       Impact factor: 7.842

Review 3.  Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review.

Authors:  Giovanni Maria Iannantuono; Silvia Riondino; Stefano Sganga; Mario Roselli; Francesco Torino
Journal:  Int J Mol Sci       Date:  2022-04-03       Impact factor: 5.923

4.  ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217.

Authors:  Naoto Kuroda; Kiril Trpkov; Yuan Gao; Maria Tretiakova; Yajuan J Liu; Monika Ulamec; Kengo Takeuchi; Abbas Agaimy; Christopher Przybycin; Cristina Magi-Galluzzi; Soichiro Fushimi; Fumiyoshi Kojima; Malthide Sibony; Jen-Fan Hang; Chin-Chen Pan; Asli Yilmaz; Farshid Siadat; Emiko Sugawara; Pierre-Alexandre Just; Nikola Ptakova; Ondrej Hes
Journal:  Mod Pathol       Date:  2020-05-28       Impact factor: 7.842

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.